GlaxoSmithKline May Not Launch Synflorix Vaccine in U.S.

LONDON, Feb 5 (Reuters) - GlaxoSmithKline Plc may not launch its new pneumococcal vaccine Synflorix in the United States, opting for a different product instead, its chief executive said on Thursday.